Submit Deal

VYNE THERAPEUTICS INC

HQ - Bridgewater

Summary

Vyne Therapeutics is a biotechnology company that focuses on developing novel therapeutics to address unmet medical needs in the field of oncology.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 347 M

Avg. Deal Size£ 347 M

Market Context

Senior Management

Sort

vyne therapeutics (molecule stabilization technology)

HQ - United States

Pharmaceuticals

13 Jan 2022

Investment Date

100%

Stake

£ 346 M

Deal Value